Very restrictive versus standard RBC transfusion strategy in anemic critically ill patients (VeRTEx): protocol for a pilot randomized controlled trial
This trial was registered at highly restrictive vs normal red blood cell transfusion strategy in anemic critically ill patients - A feasibility trial | Research with human participants (identifier: NL-OMON57318) at 12th of February 2025.
Authors
- Jimmy Schenk (ORCID: https://orcid.org/0000-0003-0570-0017)
- Alexander P.J. Vlaar
- L. Oomen (ORCID: https://orcid.org/0009-0001-3634-5129)
- Caroline M. Schaap
- Tessa A. van der Meer
- Bart .J. Biemond
- R.B. Klanderman
- Marcella C.A. Müller
Institutions
- Amsterdam University Medical Centers (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Transfusion Clinique et Biologique
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.tracli.2026.02.001
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.00